Results 211 to 220 of about 52,496 (299)

Neurons in a Dish: A Review of In Vitro Cell Models for Studying Neurogenesis

Journal of Neurochemistry, Volume 170, Issue 1, January 2026.
Different in vitro cell models are valuable to study the different steps of neurogenesis, from the proliferation of neural stem and progenitor cells to the maturation of neurons. Pluripotent stem cells (including embryonic stem cells and induced pluripotent stem cells), immortalized human neuroblastoma cell lines (SH‐SY5Y, IMR‐32), and primary brain ...
Mariana Vassal, Ana C. Cruz, Sandra Rebelo, Filipa Martins   +3 more
wiley   +1 more source

Ethylatropine Bromide as a Peripherally Restricted Muscarinic Antagonist. [PDF]

ACS Chem Neurosci, 2017
Rojas A, Ganesh T, Walker A, Dingledine R.   +3 more
europepmc   +1 more source

The Association Between Use of Inhaled Corticosteroids and Long‐Acting Beta2‐Agonists During Pregnancy and Adverse Fetal Outcomes

Respirology, Volume 31, Issue 1, Page 32-41, January 2026.
This study updated safety evidence on ICS and LABA use in pregnant women with asthma. After adjusting confounders, there was no association between ICS or LABA use and adverse fetal outcomes. However, high‐dose ICS exposure was associated with a higher risk of congenital anomalies among ICS users.
Yea‐Chwen Wu, I‐Te Wang, Hsin‐Yi Huang, Chung‐Hsuen Wu   +3 more
wiley   +1 more source

Nebulized Versus Dry Powder Long-Acting Muscarinic Antagonist Bronchodilators in Patients With COPD and Suboptimal Peak Inspiratory Flow Rate. [PDF]

Chronic Obstr Pulm Dis, 2019
Mahler DA, Ohar JA, Barnes CN, Moran EJ, Pendyala S, Crater GD.   +5 more
europepmc   +1 more source

Comparative Causal Analysis of the Effects of Long-Acting Muscarinic Antagonist Versus No Long-Acting Bronchodilator Use on Readmission or Mortality After Hospitalization for Chronic Obstructive Pulmonary Disease. [PDF]

Drugs Real World Outcomes, 2020
Roberts MH, Mapel DW, Petersen H.
europepmc   +1 more source

Muscarinic receptor antagonists for the treatment of chronic obstructive pulmonary disease

, 2014
Maria Gabriella Matera, Paola Rogliani, Mario Cazzola   +2 more
openalex   +2 more sources

Intraocular Pressure Increase Induced by 0.5% Tropicamide‐0.5% Phenylephrine in Dogs: An Analysis of Causes Using Ultrasound Biomicroscopy

Veterinary Ophthalmology, Volume 29, Issue 1, January 2026.
ABSTRACT Purpose To determine whether the differences in intraocular pressure (IOP) change after the topical application of 0.5% tropicamide and 0.5% phenylephrine (TP) are due to anatomical variations in the anterior chamber using ultrasound biomicroscopy (UBM).
Donghee Kim, Sang‐Eun Park, Haerin Yoon, Jiyi Hwang, Ji Seung Jung, Soohyun Kim, Kyung‐Mee Park   +6 more
wiley   +1 more source

Practical considerations when prescribing a long-acting muscarinic antagonist for patients with COPD. [PDF]

Int J Chron Obstruct Pulmon Dis, 2018
D'Urzo AD, Kardos P, Wiseman R.
europepmc   +1 more source

Two-point immobilization of M3 muscarinic receptor: a method for recognizing receptor antagonists in natural products [PDF]

Xiaomin Huang, Ting Wang, Ludan Wang, Yantao Sun, Ziru Zhang, Yajun Zhang   +5 more
openalex   +1 more source

Comparison of pilocarpine‐ versus exercise‐induced sweat sodium concentration across exercise intensities in trained athletes

Physiological Reports, Volume 14, Issue 1, January 2026.
Abstract Pilocarpine‐induced sweat testing offers a laboratory‐based method for assessing sweat composition, but its comparability to exercise sweating remains unclear. Establishing a relationship between this resting test and exercise sweating is important for practitioners when in‐exercise sampling is impractical.
Christopher T. Harris, Lindsey Hunt, Sam O. Shepherd, Tamara D. Hew‐Butler, Andrew V. Blow   +4 more
wiley   +1 more source